Mon–Fri 8am–6pm ET
Contact

PGY-1 Residency Program

Connect to your future in compounding pharmacy.

Revelation Pharma PGY1 Community-Based Pharmacy Residency Purpose

GY1 residency programs build upon Doctor of Pharmacy education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives. Residents who successfully complete PGY1 residency programs will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) residencies.

In addition to patient care experiences commonly encountered in community-based pharmacy settings, the Revelation Pharma PGY1 Community-Based Pharmacy Residency offers additional training opportunities in sterile and nonsterile compounding, clinical research and formulation development, business administration and pharmacy advocacy. The Revelation Pharma PGY1 Community-Based Pharmacy Residency prepares pharmacist practitioners to serve as highly qualified independent practitioners who are able to:

  • Demonstrate expertise in the field of sterile and nonsterile compounding;
  • Optimize patient outcomes through personalized medication management and utilization of novel formulations to meet individualized needs of patients;
  • Develop, create, implement, and adhere to sophisticated quality assurance programs;
  • Navigate the intricate regulatory landscape surrounding compounding and ensure adherence to guidelines set by the FDA, USP, and PCAB;
  • Identify and implement efficiencies to increase pharmacy productivity while controlling costs; and
  • Serve in managerial roles within community pharmacies.

About Innovation Compounding

Innovation Compounding is part of the Revelation Pharma Network and supports over 7,000 prescribers, 80,000+ patients and provides over 100,000 prescriptions across the nation every year.

Innovation Compounding’s therapeutic specialties include allergy, immunotherapy, dermatology/cosmeceutical medicine, functional medicine, geriatrics, hospice/long-term care, infectious disease, intravenous/intramuscular nutrition, men’s health, pain management, pediatrics, veterinary, weight management, and women’s health.

Orientation

Learning Experiences

Longitudinal

  • Innovation Compounding Patient Care
  • Leader-Development
  • Business Administration and Pharmacy Advocacy
  • Clinical Liaison Consultation Patient Care
  • Quality Assurance, Quality Compliance, and Regulatory Affairs
  • Research Project
  • Staffing at Innovation Compounding Pharmacy (four days each month)
  • Texas Tech University Health Sciences Center Teaching and Learning Curriculum Program with Teaching Certificate

Rotational

  • Ambulatory Care (two learning experiences with Emory Healthcare)
  • Formulation Research and Development
  • Pharmacy Logistics: Manager’s Perspective
  • USP 795 and USP 800 Nonsterile Compounding
  • USP 797 and USP 800 Sterile Compounding
  • Elective learning experiences will be developed based on resident interest and preceptor availability.
Benefits

Why Residents Choose Our Program

Stipend: $54,000 for a 52-week appointment term beginning June 28, 2027

Additional Benefits:

  • Educational conference stipend: $5,000
  • Paid time off: 80 hours
  • Sick time: up to 48 hours
  • Seven holidays and one floating holiday
  • Health, dental, vision, life insurance, and supplemental benefits
  • 401K retirement plan
  • Employee Assistance Program
  • Travel Assistance Program

Application Package (via PhORCAS)

  • PhORCAS Code: 315615
  • Cover letter
  • Curriculum vitae
  • Three letters of recommendation (please use the PhORCAS Recommendation Form)
  • Pharmacy school transcripts

Deadline for Submitting Application Materials:

Deadline: xx/xx/2027

Ask a question

Program Leadership

Brandon Sucher

Residency Program Director

bsucher@revelationpharma.com

Elaina Baaklini

Residency Program Director

ebaaklini@innovationcompounding.com

Current Residents

Patrice Jamison

pjamison@revelationpharma.com

Ryan Ngomsu Sakam

rnsakam@revelationpharma.com

Former Residents

Katherine Moutis

Following the successful completion of her residency program, Katherine Moutis has accepted a position at Eagle Pharma.

Kayla Garris

Following the successful completion of her residency program, Kayla Garris has joined the staff at Stanley Pharmacy.

Jonathan Reynolds

Following the success completion of his residency program, Jonathan stayed on with Innovation Compounding as a Staff Pharmacist.

Who Can Apply

  • Graduate of a Doctor of Pharmacy program from an ACPE-accredited school or college of pharmacy
  • Legal working status in United States to cover the entire period of residency training (we are unable to sponsor visas for residents)
  • Eligibility for pharmacist licensure in the state of Georgia
  • Negative drug testing results